{"id":"https://openalex.org/W2990636062","doi":"https://doi.org/10.1177/2381468319892237","title":"How Should the Value Attributes of Novel Antibiotics Be Considered in Reimbursement Decision Making?","display_name":"How Should the Value Attributes of Novel Antibiotics Be Considered in Reimbursement Decision Making?","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2990636062","doi":"https://doi.org/10.1177/2381468319892237","mag":"2990636062","pmid":"https://pubmed.ncbi.nlm.nih.gov/31910245"},"language":"en","primary_location":{"id":"doi:10.1177/2381468319892237","doi":"https://doi.org/10.1177/2381468319892237","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2381468319892237","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/2381468319892237","source":{"id":"https://openalex.org/S4210205517","display_name":"MDM Policy & Practice","issn_l":"2381-4683","issn":["2381-4683"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MDM Policy &amp; Practice","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/2381468319892237","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020431979","display_name":"Alec Morton","orcid":"https://orcid.org/0000-0003-3803-8517","observed_orcids":["https://orcid.org/0000-0003-3803-8517"]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Alec Morton","raw_affiliation_strings":["University of Strathclyde, Glasgow, UK"],"raw_orcid":"https://orcid.org/0000-0003-3803-8517","affiliations":[{"raw_affiliation_string":"University of Strathclyde, Glasgow, UK","institution_ids":["https://openalex.org/I181647926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023199622","display_name":"Abigail R. Colson","orcid":"https://orcid.org/0000-0002-3241-5855","observed_orcids":["https://orcid.org/0000-0002-3241-5855"]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Abigail Colson","raw_affiliation_strings":["University of Strathclyde, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Strathclyde, Glasgow, UK","institution_ids":["https://openalex.org/I181647926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079836504","display_name":"Axel Leporowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Axel Leporowski","raw_affiliation_strings":["University of Heidelberg, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Heidelberg, Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041560138","display_name":"Anna Trett","orcid":"https://orcid.org/0009-0001-5421-8721","observed_orcids":["https://orcid.org/0009-0001-5421-8721"]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]},{"id":"https://openalex.org/I4210163355","display_name":"Center for Disease Dynamics, Economics and Policy","ror":"https://ror.org/05fcqx592","country_code":"IN","type":"nonprofit","lineage":["https://openalex.org/I1338678786","https://openalex.org/I4210163355"]}],"countries":["GB","IN"],"is_corresponding":false,"raw_author_name":"Anna Trett","raw_affiliation_strings":["Center for Disease Dynamics, Economics & Policy, New Delhi, India","University of Strathclyde, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Disease Dynamics, Economics & Policy, New Delhi, India","institution_ids":["https://openalex.org/I4210163355"]},{"raw_affiliation_string":"University of Strathclyde, Glasgow, UK","institution_ids":["https://openalex.org/I181647926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019303155","display_name":"Taimur Bhatti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"Roche (Switzerland)","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Taimur Bhatti","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088575114","display_name":"Ramanan Laxminarayan","orcid":"https://orcid.org/0000-0002-1390-9016","observed_orcids":["https://orcid.org/0000-0002-1390-9016"]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]},{"id":"https://openalex.org/I20089843","display_name":"Princeton University","ror":"https://ror.org/00hx57361","country_code":"US","type":"education","lineage":["https://openalex.org/I20089843"]},{"id":"https://openalex.org/I4210163355","display_name":"Center for Disease Dynamics, Economics and Policy","ror":"https://ror.org/05fcqx592","country_code":"IN","type":"nonprofit","lineage":["https://openalex.org/I1338678786","https://openalex.org/I4210163355"]},{"id":"https://openalex.org/I4405268937","display_name":"High Meadows Environmental Institute","ror":"https://ror.org/02hgay921","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405268937"]}],"countries":["GB","IN","US"],"is_corresponding":false,"raw_author_name":"Ramanan Laxminarayan","raw_affiliation_strings":["Center for Disease Dynamics, Economics & Policy, New Delhi, India","Princeton Environmental Institute, Princeton University, Princeton, New Jersey","University of Strathclyde, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Disease Dynamics, Economics & Policy, New Delhi, India","institution_ids":["https://openalex.org/I4210163355"]},{"raw_affiliation_string":"Princeton Environmental Institute, Princeton University, Princeton, New Jersey","institution_ids":["https://openalex.org/I20089843","https://openalex.org/I4405268937"]},{"raw_affiliation_string":"University of Strathclyde, Glasgow, UK","institution_ids":["https://openalex.org/I181647926"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5020431979"],"corresponding_institution_ids":["https://openalex.org/I181647926"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":{"value":2500,"currency":"USD","value_usd":2500},"fwci":2.4729,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.91121926,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"4","issue":"2","first_page":"2381468319892237","last_page":"2381468319892237"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.012199999764561653,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/new-antibiotics","display_name":"novel antibiotics","score":0.9959999918937683},{"id":"https://openalex.org/keywords/value-based-payment","display_name":"value-based payment","score":0.5379999876022339},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.9869999885559082},{"id":"https://openalex.org/keywords/social-values","display_name":"social values","score":0.8550000190734863},{"id":"https://openalex.org/keywords/reimbursement-decision-making","display_name":"reimbursement decision-making","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.8751871585845947},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.6711627244949341},{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.5864030122756958},{"id":"https://openalex.org/C136197465","wikidata":"https://www.wikidata.org/wiki/Q1729295","display_name":"Variety (cybernetics)","level":2,"score":0.5105592012405396},{"id":"https://openalex.org/C201236551","wikidata":"https://www.wikidata.org/wiki/Q7310809","display_name":"Relative value","level":2,"score":0.5058333873748779},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4605063796043396},{"id":"https://openalex.org/C21333345","wikidata":"https://www.wikidata.org/wiki/Q1519843","display_name":"Health technology","level":3,"score":0.43336406350135803},{"id":"https://openalex.org/C539667460","wikidata":"https://www.wikidata.org/wiki/Q2414942","display_name":"Management science","level":1,"score":0.4152667820453644},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.40684449672698975},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37587225437164307},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36506444215774536},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.35030025243759155},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.33253559470176697},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.29686999320983887},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.242294043302536},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.13355880975723267},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07255735993385315},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.1177/2381468319892237","doi":"https://doi.org/10.1177/2381468319892237","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2381468319892237","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/2381468319892237","source":{"id":"https://openalex.org/S4210205517","display_name":"MDM Policy & Practice","issn_l":"2381-4683","issn":["2381-4683"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MDM Policy &amp; Practice","raw_type":"journal-article"},{"id":"pmid:31910245","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31910245","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MDM policy & practice","raw_type":"Journal Article"},{"id":"pmh:oai:strathprints.strath.ac.uk:70530","doi":null,"is_oa":true,"landing_page_url":"https://strathprints.strath.ac.uk/view/author/107437.html>","pdf_url":"https://strathprints.strath.ac.uk/70530/7/Morton_etal_MDMPP_2019_How_should_the_value_attributes_of_novel_antibiotics_be_considered.pdf","source":{"id":"https://openalex.org/S4306402226","display_name":"Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I181647926","host_organization_name":"University of Strathclyde","host_organization_lineage":["https://openalex.org/I181647926"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:europepmc.org:5899182","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6935770","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6935770","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6935770","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"MDM Policy Pract","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:3408ac73d86447759b675061ac46aab4","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3408ac73d86447759b675061ac46aab4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"MDM Policy & Practice, Vol 4 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1177/2381468319892237","doi":"https://doi.org/10.1177/2381468319892237","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2381468319892237","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/2381468319892237","source":{"id":"https://openalex.org/S4210205517","display_name":"MDM Policy & Practice","issn_l":"2381-4683","issn":["2381-4683"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MDM Policy &amp; Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Peace, justice, and strong institutions","score":0.5600000023841858,"id":"https://metadata.un.org/sdg/16"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7568068500","display_name":"DRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE","funder_award_id":"115618","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2990636062.pdf","grobid_xml":"https://content.openalex.org/works/W2990636062.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1166327042","https://openalex.org/W1607389874","https://openalex.org/W1977897138","https://openalex.org/W1992705769","https://openalex.org/W2011259658","https://openalex.org/W2027044592","https://openalex.org/W2037676386","https://openalex.org/W2050411686","https://openalex.org/W2094834705","https://openalex.org/W2098216677","https://openalex.org/W2107723283","https://openalex.org/W2110127034","https://openalex.org/W2111855688","https://openalex.org/W2150528543","https://openalex.org/W2165489040","https://openalex.org/W2271895099","https://openalex.org/W2409405461","https://openalex.org/W2610760615","https://openalex.org/W2616409827","https://openalex.org/W2691924305","https://openalex.org/W2759360415","https://openalex.org/W2970510331","https://openalex.org/W2984280663"],"related_works":["https://openalex.org/W2381272187","https://openalex.org/W2341734247","https://openalex.org/W2738165978","https://openalex.org/W2205124790","https://openalex.org/W2906514884","https://openalex.org/W2039854875","https://openalex.org/W4229850741","https://openalex.org/W2945320068","https://openalex.org/W1974060941","https://openalex.org/W3179553239"],"abstract_inverted_index":{"Antibiotics":[0],"have":[1,98],"revolutionized":[2],"the":[3,24,45,68,86,91,146,149,153,171],"treatment":[4],"of":[5,31,51,71,85,90,135,148,156,174],"bacterial":[6],"infections.":[7],"However,":[8],"it":[9,127],"is":[10,15],"widely":[11],"held":[12],"that":[13,73,88,169],"there":[14],"underinvestment":[16],"in":[17,137,162,166],"antibiotics":[18,53,158],"research":[19],"and":[20,48,56,185],"development":[21],"relative":[22],"to":[23,54,76,124,131,180],"socially":[25],"optimal":[26],"level":[27],"for":[28,66],"a":[29,83,121,138,167],"number":[30],"reasons.":[32],"In":[33],"this":[34],"article,":[35],"we":[36],"discuss":[37],"whether":[38],"existing":[39],"health":[40,104,182],"technology":[41,105],"assessment":[42,106],"procedures":[43],"recognize":[44],"full":[46,172],"economic":[47],"societal":[49],"value":[50,72,92,136],"new":[52],"patients":[55],"society":[57],"when":[58,108],"making":[59],"reimbursement":[60,163],"decisions.":[61],"We":[62,79,119,142],"present":[63,120],"three":[64],"recommendations":[65],"modelling":[67],"unique":[69,154],"attributes":[70,155],"are":[74,112],"specific":[75],"novel":[77,157],"antibiotics.":[78],"find,":[80],"based":[81],"on":[82],"review":[84],"literature,":[87],"some":[89],"elements":[93],"proposed":[94],"by":[95,103,144],"our":[96],"framework":[97],"previously":[99],"been":[100],"discussed":[101],"qualitatively":[102],"bodies":[107],"evaluating":[109],"antibiotics,":[110],"but":[111],"not":[113],"yet":[114],"formally":[115],"captured":[116],"via":[117],"modelling.":[118],"worked":[122],"example":[123],"show":[125],"how":[126],"may":[128],"be":[129,160],"possible":[130],"capture":[132],"these":[133,176],"dimensions":[134],"more":[139],"quantitative":[140],"manner.":[141],"conclude":[143],"answering":[145],"question":[147],"title":[150],"as":[151],"follows:":[152],"should":[159],"considered":[161],"decision":[164],"making,":[165],"way":[168],"captures":[170],"range":[173],"benefits":[175],"important":[177],"technologies":[178],"bring":[179],"patients,":[181],"care":[183],"systems,":[184],"society.":[186]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}
